Time & Location:
May 9th 2009 (Saturday) 9:00-19:30
Conference Room B, AP52, Abbott Laboratories,
100 Abbott Park Road, North Chicago, IL 60064
Eevent Agenda:
9:00-9:30 Registration/ Poster Mounting
9:30-9:45 Welcome
9:45-10:30 Leading Research through Challenging Times in the Pharmaceutical Industry:
Opportunities for Future Success
James Summers, Ph.D., Divisional Vice President, Neuroscience and Pain Research, Abbott Labs
10:30-11:15 Developing Yourself and Others: Re-Tooling in a Time of Change in Healthcare
Sumant Ramachandra, M.D., Ph.D, Chief Scientific Officer, Senior Vice President, Research & Development and Medical & Regulatory Affairs, Hospira
11:15-11:25 Break
11:25-12:30 Poster Presentation Competition
12:30-14:30 Poster Paper Competition
Career Counseling
Lunch Break
14:30-15:15 Shenhua’s Strategy in Coal Chemical Industry and Innovation in Low-Carbon Energy Technologies
Wenjiang Zhang, Ph.D., Vice President, Shenhua Group Corporation, Limited, Beijing, China
15:15-16:00 Opportunities in Challenging Times: Employment
Jamie Stacey, Director, Talent Acquisition, Global Operations, Abbott Labs
16:00-16:15 Break / Final Competition Ballot Casting
16:15-16:30 Poster Competition Award and Closing Remark
17:30-18:45 Conference Dinner (Optional) at Yan’s Hunan Inn II
17:30-19:30 Sustainable Energy Supply and Security; in Times of Crises It Is the Time for Leadership to Perform
Carlos Cabrera, Board Chairman, UOP, A Honeywell Company
Guest Speakers:
Leading Research through Challenging Times in the Pharmaceutical Industry:Opportunities for Future Success - Dr. James Summers
Dr. James Summers
Divisional Vice President, Neuroscience and Pain Research, Abbott Labs
Abstract
Powerful forces are threatening the future of the pharmaceutical industry. Increasing pressure on health care spending, growing regulatory conservatism, declining productivity, and escalating generic competition are challenging future success. More than ever pharmaceutical research organizations must adopt new strategies to efficiently identify best-in-class products with unquestionable benefit versus risk. We must focus on commercially attractive disease areas of high unmet medical need. We must maximize R&D investment by driving to unprecedented levels of productivity and efficiency. We must achieve a balance of innovative new approaches and meaningful improvements on old ones. Through the execution of new research strategies, we have an opportunity to sustain the success of our industry and deliver ground-breaking new drugs that improve the lives of patients.
Developing Yourself and Others: Re-Tooling in a Time of Change in Healthcare - Dr. Sumant Ramachandra
Shenhua’s Strategy in Coal Chemical Industry and Innovation in Low-Carbon Energy Technologies - Dr. Wenjiang Zhang
Sustainable Energy Supply and Security; in Times of Crises It Is the Time for Leadership to Perform - Mr. Carlos Cabrera
Comments